Circulating Noncoding RNAs as Candidate Biomarkers of Endocrine and Metabolic Diseases
نویسندگان
چکیده
منابع مشابه
Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
The discovery of thousands of noncoding RNAs (ncRNAs) has expanded our view on mammalian genomes and transcriptomes, as well as their organization and regulation. Accumulating evidence on aberrantly regulated ncRNAs, including short microRNAs, long ncRNAs and circular RNAs, across various heart diseases indicates that ncRNAs are critical contributors to cardiovascular pathophysiology. In additi...
متن کاملLong Noncoding RNAs as Biomarkers in Cancer
Long noncoding RNAs (lncRNAs) are a relatively well-characterized class of noncoding RNA (ncRNA) molecules, involved in the regulation of various cell processes, including transcription, intracellular trafficking, and chromosome remodeling. Their deregulation has been associated with the development and progression of various cancer types, the fact which makes them suitable as biomarkers for ca...
متن کاملNoncoding RNAs in Neurodegenerative Diseases
Noncoding RNAs are widely known for their various essential roles in the development of central nervous system. It involves neurogenesis, neural stem cells generation, maintenance and maturation, neurotransmission, neural network plasticity, formation of synapses, and even brain aging and DNA damage responses. In this review, we will discuss the biogenesis of microRNA, various functions of nonc...
متن کاملNoncoding RNAs in human saliva as potential disease biomarkers
Human saliva emerged as a research material in as early as the 17th century when investigators sought to understand the basis for salivary secretion (Garrett, 1975). Over the centuries, the focus of salivary research has evolved greatly and a wide range of topics has been examined (Garrett, 1975; Schipper et al., 2007). It is now known that the functions of saliva include at least lubrication, ...
متن کاملNoncoding RNAs as Novel Biomarkers in Prostate Cancer
Prostate cancer (PCa) is the second most common diagnosed malignant disease in men worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it also led to an overdiagnosis and as a consequence to an overtreatment of patients with an indolent disease. New biomarkers for diagnosis, prediction, and monitoring of the disease are needed. These biomarkers would enable the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Endocrinology
سال: 2018
ISSN: 1687-8337,1687-8345
DOI: 10.1155/2018/9514927